Radiation oncology firm Elekta has received an order for two Versa HD linear accelerators.
The purchase comes from St. James's Institute of Oncology in Leeds, England.
St. James's clinicians plan to use the Versa HD prioritize the treatment of inoperable lung cancer patients, in addition to those with prostate cancer.